Read-Through Therapeutics Reduce Cystogenesis in a Novel Cohort of CRISPR Base Edited ADPKD Organoids
Courtney E. Vishy(University of Washington), Benjamin Freedman(GTx (United States)), Daniel K. Crawford(Eloxx Pharmaceuticals (United States)), Matthew M. Goddeeris(University of Pennsylvania)
Cited by 0
Related Papers
Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids
|Nature Communications|2015|769
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
|Science Translational Medicine|2022|118
ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins
|Journal of Pharmacology and Experimental Therapeutics|2020|54